Written by the Nuvirox Research Team
Key points
- Retinal (retinaldehyde) is one conversion step from retinoic acid, the form that acts on skin cells. Retinol is two steps away, so retinal is generally the stronger of the two over-the-counter options.
- Retinaldehyde has controlled human trials for wrinkles and texture, but direct retinal-vs-retinol trials are few, small, and often tied to specific formulations.
- Prescription tretinoin still has the deepest evidence. Retinal sits between retinol and tretinoin on both strength and irritation, and every retinoid needs a pregnancy conversation first.
Short answer: retinal is usually the stronger choice, with honest caveats. Retinal (retinaldehyde) converts to retinoic acid in one enzymatic step, while retinol needs two, so retinal reaches the active form more directly and has shown wrinkle and texture improvements in controlled trials at 0.05–0.1%. But the head-to-head evidence against retinol is thin: one small split-face study, using a special delivery system. Neither one has the track record of prescription tretinoin. The fair reading is that retinal is a reasonable step up for people who tolerate retinol well and want more effect without a prescription.
What is the actual difference between retinal and retinol?
The difference is how many conversion steps each needs before it can act on skin. Both are forms of vitamin A, but skin cells respond to only one form: all-trans retinoic acid, the molecule that binds retinoic acid receptors in the cell nucleus and switches on the genes involved in cell turnover and collagen production.
Everything sold over the counter is a precursor that skin enzymes have to convert. Retinyl esters (such as retinyl palmitate) first become retinol. Retinol is then oxidized to retinaldehyde, and that step is slow and rate-limiting. Retinaldehyde is then oxidized to retinoic acid. Retinal enters this pathway one step later than retinol, so less of it is lost along the way. Prescription tretinoin is retinoic acid itself and skips conversion entirely.
Is retinal really stronger than retinol?
On the biology, yes. Retinal produces a stronger retinoid response in human skin than retinol, though the effect is still short of retinoic acid. In a Geneva study of topical retinaldehyde, researchers measured induction of CRABP-2, a marker protein that rises when skin responds to retinoic acid. The rank order was retinoic acid first, then retinaldehyde, then retinol (ref 6). The same team saw dose-dependent epidermal thickening and more proliferating cells with 0.05–0.5% retinaldehyde over one to three months.
Retinol is still active. A University of Michigan study applied retinol under occlusion and found epidermal thickening and receptor-protein changes similar to retinoic acid. Measurable retinoic acid did not rise, and redness stayed close to vehicle (ref 3). That suggests a large share of retinol is stored as retinyl esters rather than converted, which helps explain why retinol is gentler and usually slower.
You will also see multipliers in marketing, such as retinal working "X times faster." We couldn't find a controlled human trial that measured a figure like that, so treat them as claims, not findings.
How do retinal, retinol, and tretinoin compare side by side?
Retinal sits between the two on strength and on irritation. Here is how the three compare on the factors that matter most for wrinkles and collagen.
| Factor | Retinol | Retinal (retinaldehyde) | Tretinoin |
|---|---|---|---|
| Steps to retinoic acid | Two | One | None (it is retinoic acid) |
| Access | Over the counter | Over the counter | Prescription (in the US) |
| Typical trial strengths | 0.05–0.4% | 0.05–0.1% | 0.025–0.1% |
| Irritation in trials | Lowest | Low to moderate | Highest, dose-dependent |
| Quality of wrinkle evidence | Mixed; several null trials | Moderate; small trials, some vs. tretinoin | Strongest; multiple RCTs |
| Stability | Light/air sensitive | More unstable; formulation matters | Stable in approved products |
What human studies actually show
Retinal vs. prescription retinoic acid (Creidi, 1998). In a controlled trial in 125 adults with facial photodamage, participants used 0.05% retinaldehyde, 0.05% retinoic acid, or the retinaldehyde vehicle for up to 44 weeks. Researchers measured crow's-feet wrinkles on silicone skin replicas. Both active creams significantly reduced wrinkle and roughness measures at week 18, and the vehicle did not. Retinaldehyde was well tolerated, while retinoic acid caused more irritation and hurt adherence. One limitation: the improvement was less pronounced at week 44 than at week 18 (ref 2).
Two retinal strengths (Kwon, 2018). In a randomized double-blind trial, 40 Korean women applied 0.1% or 0.05% retinaldehyde twice daily for 3 months. Both groups improved skin texture (about 13%), hydration, and water loss, and both strengths were well tolerated. The two strengths were not statistically different on most outcomes, and there was no untreated control arm (ref 5).
The closest head-to-head (Kim, 2021). In a randomized split-face study, 23 adults applied retinaldehyde in multilamellar vesicles on one side of the face and retinol at matched strengths (0.05%/0.1%) on the other for 8 weeks. Both sides improved in wrinkle depth, hydration, and elasticity, and the retinal side did significantly better on most objective measures, though not dermal density. No adverse events were reported. The catch is that the retinal used a specialized delivery system, the sample was small, and the trial was short, so it doesn't cleanly settle retinal vs. retinol as molecules (ref 7).
Retinol on aged skin (Kafi, 2007). In a randomized, double-blind, vehicle-controlled trial, 36 older adults (mean age 87) had 0.4% retinol lotion applied to one arm and vehicle to the other, up to three times a week for 24 weeks. Fine wrinkling improved significantly on the retinol arm. Biopsies from small subgroups showed more glycosaminoglycans and procollagen I (ref 1). This is among the better retinol trials, but it used arm skin, not the face.
The counterweight: OTC retinol evidence is weak (Spierings, 2021). A systematic review of nine randomized, double-blind, vehicle-controlled trials of over-the-counter retinol products found that four showed no significant difference from vehicle. It found that the five positive trials had major methodological weaknesses. The author concluded that trustworthy evidence for cosmetic retinol on facial aging is very limited (ref 8). That critique applies most directly to retinol, but it's a useful caution for any cosmetic retinoid claim.
Against the gold standard (Siddiqui, 2024). A 2024 systematic review of 25 studies comparing other topicals with tretinoin found that comparators were generally better tolerated. Most of those studies were of poor quality or at risk of bias. The authors named retinaldehyde as a reasonable second-line option for people who cannot tolerate tretinoin, not a replacement for it (ref 9). A separate review of tretinoin RCTs found consistent improvements in wrinkling and pigmentation over 3 to 24 months (ref 10).
What retinal won't do
Retinal won't match prescription tretinoin's evidence base, and it won't work quickly. Most trials ran 8 weeks to 6 months before measuring change. It also can't undo deep folds or sagging, which come from volume loss and gravity rather than surface wrinkling. Being a step closer to retinoic acid means more potential for dryness, flaking, and stinging than retinol, especially if you combine it with acids or scrubs. That's why stacking retinoids with other exfoliating actives deserves caution. A common worry is that long-term use makes skin fragile. The biopsy data point the other way, as we cover in whether retinol thins your skin.
Pregnancy: oral retinoids can cause birth defects. A 2015 meta-analysis of 654 pregnancies exposed to topical retinoids found no significant rise in major malformations or miscarriage. Its authors said that is reassuring after accidental exposure but not enough evidence to justify using topical retinoids during pregnancy (ref 4). If you are pregnant, trying to conceive, or breastfeeding, skip retinoids unless your clinician advises otherwise. See a dermatologist if irritation lasts beyond a few weeks, if you have rosacea or eczema, or if a spot is changing, bleeding, or not healing. That last one needs an exam, not a serum.
How to use retinal: strength, frequency, and timeline
The trials above used retinal at 0.05–0.1%, applied once or twice daily. A practical way to apply that:
- Coming from retinol? Start with 0.05% retinal two or three nights a week, then increase to nightly over 2–4 weeks if your skin stays calm.
- New to retinoids? Start with a low-strength retinol or 0.05% retinal no more than every other night. The Kang data suggest retinol's slower conversion is part of why it irritates less.
- Use a pea-sized amount for the whole face at night, on dry skin. Buffer with moisturizer if needed, and wear daily sunscreen.
- Around the eyes, the skin is thinner and reacts more. Many people use a lower strength or apply it less often there. Our review of whether eye creams boost collagen covers which periorbital ingredients have evidence.
- Give it 12 weeks before judging results. In most trials, wrinkle changes appeared between 8 and 24 weeks.
If you can't tolerate any retinoid, plant alternatives exist, though their evidence is thinner. Our comparison of bakuchiol vs retinol covers what is and isn't known.
FAQ
Should I switch from retinol to retinal?
If you've used retinol for a few months with little irritation and want more effect, retinal is a reasonable next step. If retinol already makes your skin red or flaky, retinal will probably be harder to tolerate, so make sure your routine is stable first.
Is 0.1% retinal stronger than 1% retinol?
No trial has tested that exact comparison, so nobody can give an honest exact equivalence. Retinal needs one fewer conversion step, so lower percentages can be meaningful. Formulation, stability, and delivery system probably matter as much as the number on the label.
Does retinal cause purging?
Some people report a temporary rise in breakouts in the first weeks, which fits retinoids' effect on cell turnover. It is mostly described for acne-prone skin and usually settles within about a month. Breakouts in new areas, or that keep going, are more likely irritation or a reaction to the formula.
Can I use retinal with vitamin C or niacinamide?
Generally yes, but you don't have to apply them at the same moment. A common approach is vitamin C in the morning and retinal at night. What tends to cause trouble is layering retinal with strong acids or physical exfoliants.
Do collagen supplements replace a retinoid?
No. They work differently. Topical retinoids act on skin cells directly. Oral collagen peptides have their own small body of skin-elasticity trials and are best thought of as complementary, not a substitute.
From Nuvirox
Why we formulated Collagen+ Complex
The collagen research that holds up has one thing in common: people took it every day, for weeks to months, before anything was measured. We built Collagen+ Complex to support skin, hair, nails, and joints as part of that kind of steady daily routine — alongside the basics no supplement replaces, like sun protection, enough total protein, and good sleep.
It comes with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about Collagen+ Complex →The bottom line
Retinal is one conversion step closer to the form of vitamin A that skin uses, and that shows up in the biology and in controlled trials at 0.05–0.1%. It improved wrinkles and texture, matched prescription retinoic acid in one 44-week trial, and irritated less than retinoic acid. Retinol is gentler and still useful, but its cosmetic trial record is mixed. Direct retinal-vs-retinol evidence comes down to one small, formulation-specific study. Tretinoin remains the best-studied option if you can tolerate it. Pick the strongest retinoid your skin can handle consistently, give it three months, wear sunscreen, and avoid retinoids during pregnancy.
References
- Kafi R, Kwak HS, Schumacher WE, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007;143(5):606-612. DOI: 10.1001/archderm.143.5.606. PMID: 17515510
- Creidi P, Vienne MP, Ochonisky S, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol. 1998;39(6):960-965. DOI: 10.1016/s0190-9622(98)70270-1. PMID: 9843009
- Kang S, Duell EA, Fisher GJ, et al. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol. 1995;105(4):549-556. DOI: 10.1111/1523-1747.ep12323445. PMID: 7561157
- Kaplan YC, Ozsarfati J, Etwel F, et al. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis. Br J Dermatol. 2015;173(5):1132-1141. DOI: 10.1111/bjd.14053. PMID: 26215715
- Kwon HS, Lee JH, Kim GM, Bae JM. Efficacy and safety of retinaldehyde 0.1% and 0.05% creams used to treat photoaged skin: a randomized double-blind controlled trial. J Cosmet Dermatol. 2018;17(3):471-476. DOI: 10.1111/jocd.12551. PMID: 29663701
- Saurat JH, Didierjean L, Masgrau E, et al. Topical retinaldehyde on human skin: biologic effects and tolerance. J Invest Dermatol. 1994;103(6):770-774. DOI: 10.1111/1523-1747.ep12412861. PMID: 7798613
- Kim J, Kim J, Jongudomsombat T, et al. The efficacy and safety of multilamellar vesicle containing retinaldehyde: a double-blinded, randomized, split-face controlled study. J Cosmet Dermatol. 2021;20(9):2874-2879. DOI: 10.1111/jocd.13993. PMID: 33569865
- Spierings NMK. Evidence for the efficacy of over-the-counter vitamin A cosmetic products in the improvement of facial skin aging: a systematic review. J Clin Aesthet Dermatol. 2021;14(9):33-40. PMCID: PMC8675340. PMID: 34980969
- Siddiqui Z, Zufall A, Nash M, et al. Comparing tretinoin to other topical therapies in the treatment of skin photoaging: a systematic review. Am J Clin Dermatol. 2024;25(6):873-890. DOI: 10.1007/s40257-024-00893-w. PMID: 39348007
- Sitohang IBS, Makes WI, Sandora N, Suryanegara J. Topical tretinoin for treating photoaging: a systematic review of randomized controlled trials. Int J Womens Dermatol. 2022;8(1):e003. DOI: 10.1097/JW9.0000000000000003. PMCID: PMC9112391. PMID: 35620028
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.